Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：118 Table Number：137
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global NSAIDs market in this environment. In terms of revenue, this research report indicated that the global NSAIDs market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of NSAIDs industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Roche aims at producing XX K Units NSAIDs in 2020, with XX % production to take place in global market, Amgen accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of NSAIDs Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in NSAIDs Market? Roche Amgen B-MS Merck Pfizer Novartis Eli Lilly and Company Johnson and Johnson GSK Sanofi Boehringer Ingelheim Zhejiang Jiuzhou Pharmaceutical ... Major Type of NSAIDs Covered in XYZResearch report: Ibuprofen Aspirin Paracetamol Diclofenac Others Application Segments Covered in XYZResearch Market Tablets Capsules Suspension Topical Preparations Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global NSAIDs Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Ibuprofen -Product Introduction and Major Manufacturers 1.1.2 Aspirin -Product Introduction and Major Manufacturers 1.1.3 Paracetamol -Product Introduction and Major Manufacturers 1.1.4 Diclofenac -Product Introduction and Major Manufacturers 1.1.5 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global NSAIDs Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China NSAIDs Market 3.1.1 Top Companies leading NSAIDs Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China NSAIDs Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU NSAIDs Market 3.2.1 Top Companies leading NSAIDs Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU NSAIDs Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA NSAIDs Market 3.3.1 Top Companies leading NSAIDs Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA NSAIDs Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan NSAIDs Market 3.4.1 Top Companies leading NSAIDs Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan NSAIDs Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India NSAIDs Market 3.5.1 Top Companies leading NSAIDs Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India NSAIDs Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia NSAIDs Market 3.6.1 Top Companies leading NSAIDs Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia NSAIDs Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America NSAIDs Market 3.7.1 Top Companies leading NSAIDs Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America NSAIDs Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 NSAIDs Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on NSAIDs Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global NSAIDs Sales and Growth Rate (2021-2027) 5.2 Global NSAIDs Sales Value and Growth Rate (2021-2027) 6 NSAIDs Competitive Analysis 6.1 Roche 6.1.1 Roche Company Profiles 6.1.2 Roche Product Introduction 6.1.3 Roche NSAIDs Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Amgen 6.2.1 Amgen Company Profiles 6.2.2 Amgen Product Introduction 6.2.3 Amgen NSAIDs Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 B-MS 6.3.1 B-MS Company Profiles 6.3.2 B-MS Product Introduction 6.3.3 B-MS NSAIDs Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Merck 6.4.1 Merck Company Profiles 6.4.2 Merck Product Introduction 6.4.3 Merck NSAIDs Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Pfizer 6.5.1 Pfizer Company Profiles 6.5.2 Pfizer Product Introduction 6.5.3 Pfizer NSAIDs Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 Novartis 6.6.1 Novartis Company Profiles 6.6.2 Novartis Product Introduction 6.6.3 Novartis NSAIDs Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 6.7 Eli Lilly and Company 6.7.1 Eli Lilly and Company Company Profiles 6.7.2 Eli Lilly and Company Product Introduction 6.7.3 Eli Lilly and Company NSAIDs Production, Revenue (2016-2021) 6.7.4 SWOT Analysis 6.8 Johnson and Johnson 6.8.1 Johnson and Johnson Company Profiles 6.8.2 Johnson and Johnson Product Introduction 6.8.3 Johnson and Johnson NSAIDs Production, Revenue (2016-2021) 6.8.4 SWOT Analysis 6.9 GSK 6.9.1 GSK Company Profiles 6.9.2 GSK Product Introduction 6.9.3 GSK NSAIDs Production, Revenue (2016-2021) 6.9.4 SWOT Analysis 6.10 Sanofi 6.10.1 Sanofi Company Profiles 6.10.2 Sanofi Product Introduction 6.10.3 Sanofi NSAIDs Production, Revenue (2016-2021) 6.10.4 SWOT Analysis 6.11 Boehringer Ingelheim 6.12 Zhejiang Jiuzhou Pharmaceutical 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global NSAIDs Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global NSAIDs Sales (K Unit) by Type (2026-2027) Figure Global NSAIDs Sales (K Unit) and Growth Rate (2026-2027) Figure Global NSAIDs Sales Market Share (%) by Type (2019 -2020) Table Global NSAIDs Sales Value (Million USD) by Type (2026-2027) Figure Global NSAIDs Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global NSAIDs Sales Value Market Share (%) by Type (2019-2020) Table Global NSAIDs Sales (K Unit) by Application (2026-2027) Table China NSAIDs Sales (K Unit) of Major Company (2016-2021) Table China NSAIDs Sales Market Share of Major Company (2016-2021) Table China NSAIDs Sales Value (Million USD) of Major Company (2016-2021) Figure China NSAIDs Sales Value (Million USD) and Growth Rate (2016-2021) Table China NSAIDs Sales Value Share of Major Company (2016-2021) Table China NSAIDs Price (USD/Unit), by Type (2019-2020) Table China NSAIDs Sales (Unit) by Type (2026-2027) Figure China NSAIDs Sales (Unit) by Type (2026-2027) Table EU NSAIDs Sales (K Unit) of Major Company (2016-2021) Table EU NSAIDs Sales Market Share of Major Company (2016-2021) Table EU NSAIDs Sales Value (Million USD) of Major Company (2016-2021) Figure EU NSAIDs Sales Value (Million USD) and Growth Rate (2016-2021) Table EU NSAIDs Sales Value Share of Major Company (2016-2021) Table EU NSAIDs Price (USD/Unit), by Type (2019-2020) Table EU NSAIDs Sales (Unit) by Type (2026-2027) Figure EU NSAIDs Sales (Unit) by Type (2026-2027) Table USA NSAIDs Sales (K Unit) of Major Company (2016-2021) Table USA NSAIDs Sales Market Share of Major Company (2016-2021) Table USA NSAIDs Sales Value (Million USD) of Major Company (2016-2021) Figure USA NSAIDs Sales Value (Million USD) and Growth Rate (2016-2021) Table USA NSAIDs Sales Value Share of Major Company (2016-2021) Table USA NSAIDs Price (USD/Unit), by Type (2019-2020) Table USA NSAIDs Sales (Unit) by Type (2026-2027) Figure USA NSAIDs Sales (Unit) by Type (2026-2027) Table Japan NSAIDs Sales (K Unit) of Major Company (2016-2021) Table Japan NSAIDs Sales Market Share of Major Company (2016-2021) Table Japan NSAIDs Sales Value (Million USD) of Major Company (2016-2021) Figure Japan NSAIDs Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan NSAIDs Sales Value Share of Major Company (2016-2021) Table Japan NSAIDs Price (USD/Unit), by Type (2019-2020) Table Japan NSAIDs Sales (Unit) by Type (2026-2027) Figure Japan NSAIDs Sales (Unit) by Type (2026-2027) Table India NSAIDs Sales (K Unit) of Major Company (2016-2021) Table India NSAIDs Sales Market Share of Major Company (2016-2021) Table India NSAIDs Sales Value (Million USD) of Major Company (2016-2021) Figure India NSAIDs Sales Value (Million USD) and Growth Rate (2016-2021) Table India NSAIDs Sales Value Share of Major Company (2016-2021) Table India NSAIDs Price (USD/Unit), by Type (2019-2020) Table India NSAIDs Sales (Unit) by Type (2026-2027) Figure India NSAIDs Sales (Unit) by Type (2026-2027) Table Southeast Asia NSAIDs Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia NSAIDs Sales Market Share of Major Company (2016-2021) Table Southeast Asia NSAIDs Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia NSAIDs Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia NSAIDs Sales Value Share of Major Company (2016-2021) Table Southeast Asia NSAIDs Price (USD/Unit), by Type (2019-2020) Table Southeast Asia NSAIDs Sales (Unit) by Type (2026-2027) Figure Southeast Asia NSAIDs Sales (Unit) by Type (2026-2027) Table South America NSAIDs Sales (K Unit) of Major Company (2016-2021) Table South America NSAIDs Sales Market Share of Major Company (2016-2021) Table South America NSAIDs Sales Value (Million USD) of Major Company (2016-2021) Figure South America NSAIDs Sales Value (Million USD) and Growth Rate (2016-2021) Table South America NSAIDs Sales Value Share of Major Company (2016-2021) Table South America NSAIDs Price (USD/Unit), by Type (2019-2020) Table South America NSAIDs Sales (Unit) by Type (2026-2027) Figure South America NSAIDs Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of NSAIDs Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of NSAIDs Figure Cost Structure of NSAIDs in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global NSAIDs Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global NSAIDs Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Roche Profiles Table Roche NSAIDs Product Introduction Table Roche NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Roche SWOT Analysis Table Amgen Profiles Table Amgen NSAIDs Product Introduction Table Amgen NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Amgen SWOT Analysis Table B-MS Profiles Table B-MS NSAIDs Product Introduction Table B-MS NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure B-MS SWOT Analysis Table Merck Profiles Table Merck NSAIDs Product Introduction Table Merck NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Merck SWOT Analysis Table Pfizer Profiles Table Pfizer NSAIDs Product Introduction Table Pfizer NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Pfizer SWOT Analysis Table Novartis Profiles Table Novartis NSAIDs Product Introduction Table Novartis NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Novartis SWOT Analysis Table Eli Lilly and Company Profiles Table Eli Lilly and Company NSAIDs Product Introduction Table Eli Lilly and Company NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Eli Lilly and Company SWOT Analysis Table Johnson and Johnson Profiles Table Johnson and Johnson NSAIDs Product Introduction Table Johnson and Johnson NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Johnson and Johnson SWOT Analysis Table GSK Profiles Table GSK NSAIDs Product Introduction Table GSK NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure GSK SWOT Analysis Table Sanofi Profiles Table Sanofi NSAIDs Product Introduction Table Sanofi NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Sanofi SWOT Analysis Table Boehringer Ingelheim Profiles Table Boehringer Ingelheim NSAIDs Product Introduction Table Boehringer Ingelheim NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Boehringer Ingelheim SWOT Analysis Table Zhejiang Jiuzhou Pharmaceutical Profiles Table Zhejiang Jiuzhou Pharmaceutical NSAIDs Product Introduction Table Zhejiang Jiuzhou Pharmaceutical NSAIDs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
